Reuters Stock Buzz Powered by SocialPicks Logo_divider Logo_thomsonreuters Bg_dots_d1
   Sign Up   |   Log In   |   What is Reuters Stock Buzz?   |   FAQ

Important Message: The Reuters Stock Buzz beta period will end Friday, October 31. If you would like to continue to access your Stock Buzz account through SocialPicks, please click here
Front Page Picks  
   Sector:  All Graphic_arrow2     Select:  Duration Graphic_arrow2
Recently Hot  |  Today  |  This Week  |  This Month  |  This Quarter  

October 14
6 pts

Graphic_rating_buy WTSLA Wet Seal (WTSLA) Turn Around and Cyclical Buy   (Rating: BUY)
   By   gman0000 gman0000   N/A   Similarity: ?%   on 10/14/08
   Filed under Services  >  Retail (Apparel)
   Comment

Fundamental Analysis  
Based upon a fundamental analysis and a discounted cash flow model.  Assumptions: <o:p> </o:p> Revenue Growth Rate: Justification:   Arden B return to profitability from -8% to breakeven or slightly positive <o:p> </o:p> Justification:   Cyclical growth during holiday period averages 24% <o:p> </o:p> <o:p>   </o:p> Cost of Sales: <o:p> </o:p> Continued reduction in costs <o:p> </...
   ... Continue reading »


October 13
9 pts

Graphic_rating_buy CKEC Bullish on CKEC ...   (Rating: BUY)
Foto
   By   Marian Filo   70%   Similarity: ?%   on 10/13/08
   Filed under Services  >  Motion Pictures
   Comment

Carmike Cinemas, Inc. operates as a motion picture exhibitor in the United States. It shows films on a first-run basis, as well as operates discount theatres. The company serves small to mid-size non-urban markets. As of December 31, 2007, it owned 69 theatres, leased 193 theatres, and operated 2 theatres under shared ownership with 2,349 screens. The company was founded in 1982 and is headquartered in Columbus, Georgia....
   ... Continue reading »


9 pts

Graphic_rating_buy ONXX Who's Next in the Biotech Buyout Frenzy?   (Rating: BUY)
Rxlogo
   By   Mike Havrilla   76%   Similarity: ?%   on 10/13/08
   Filed under Healthcare  >  Biotechnology & Drugs
   Comment

Who's Next in the Biotech Buyout Frenzy? The biotech industry is rapidly consolidating as big pharma companies put their cash stash to use in deals ranging from well-known large caps all the way down to unknown micro-caps in an effort to bolster their range of marketed products, late stage pipeline candidates, and drug discovery technology platforms. Genentech (DNA) has rejected Roche's (RHHBY) $89 bid to acquire the remaining 44% of DNA it does not already own as insuffic...
   ... Continue reading »


3 pts

Graphic_rating_buy RTN Bullish on RTN ...   (Rating: BUY)
Picture_29
   By   Sheldon Liber   49%   Similarity: ?%   on 10/13/08
   Filed under Conglomerates  >  Conglomerates
   Comment

BUY rating on Raytheon Company (RTN)

Start Price:   $46.51
Start Date:   10/13/2008

   ... Continue reading »

+


3 pts

Graphic_rating_buy IR Bullish on IR ...   (Rating: BUY)
   By   Steven Halpern   22%   Similarity: ?%   on 10/13/08
   Filed under Capital Goods  >  Misc. Capital Goods
   Comment

BUY rating on IngersollRand Company Ltd. (IR)

Start Price:   $22.25
Start Date:   10/13/2008

   ... Continue reading »

+


1 pt

Graphic_rating_buy EWT EWT   (Rating: BUY)
11235
   By   thebigkill   75%   Similarity: ?%   on 10/13/08
   Filed under Financial  >  Misc. Financial Services
   Comment

EWT
   ... Continue reading »

+
Related posts:   EWT and iShares MSCI Taiwan


1 pt

Graphic_rating_buy GE Bullish on GE ...   (Rating: BUY)
   By   stockman30   N/A   Similarity: ?%   on 10/13/08
   Filed under Conglomerates  >  Conglomerates
   Comment

best buy

Update 10/13: stockman30
nyse best buys today are ford and ge@2.50 and 21.12 on monday,0ct 13,2008

Update 10/13: ford
ford will be best gainer on nyse this year from 1.99 oct 10
   ... Continue reading »


1 pt

Graphic_rating_sell MRNA QTLY REPORT WILL CONFIRM MRNA'S DIRECTION!   (Rating: SELL)
   By   JIMMY T   19%   Similarity: ?%   on 10/13/08
   Comment

10/13/08 MRNA-YEAR TO DATE STOCK PRICE -93%. EXPENSES MONTHLY, FAR EXCEED MONTHLY REVENUE AND NO APPROVALS IN SITE. HOW MANY MORE FINANCIAL BAND AIDES CAN YOU PLACE ON THIS COMPANY. SURVIVAL FOR THE COMPANY OR MANAGEMENT IS A PARTNER. NOW SERIOUSLY, WHO WILL STEP UP TO THE PLATE TO BE A PARTNER, WITH THE CURRENT BALANCE SHEET, EXPENSES, DEBT AND WITH HARDLY ANY INCOME OR REVENUE. ESPECIALLY IN THIS MARKET ENVIRONMENT. AFTER ALL, RNAI IS IN THE BEGINNING STAGES AND SUCCESS FOR ANYONE IS NOT IN TH...
   ... Continue reading »